Geron Financial Statements
Geron Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Geron Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 7.6 | 3.3 | 6.2 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (62.8) | (47.4) | (37.7) |
| Total Net Income ($ mil.) | (36.7) | (31.4) | (33.5) |
| Diluted EPS (Net Income) | (0.62) | (0.47) | (0.58) |
Geron Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.2 | 1.7 | 4.7 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (15.5) | (15.9) | (14.3) |
| Total Net Income ($ mil.) | (13.6) | (13.7) | (11.0) |
| Diluted EPS (Net Income) | (0.17) | (0.18) | (0.22) |
Geron Stock Quote & Chart
| 11/21/08 16:00:14 EST •
NASDAQ •
3.03
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Geron Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 43.66 | 3.44 | 1.55 |
| Price/Earnings Ratio | -- | 15.44 | 15.69 |
| Price/Book Ratio | 1.75 | 2.92 | 1.50 |
| Price/Cash Flow Ratio | -- | 12.54 | 9.64 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Geron Financial Ratios
Geron Competitive Intelligence
| Alexion Pharmaceuticals | StemCells | ViaCell | |
|---|---|---|---|
| Annual Sales ($ mil.) | 72.0 | 0.1 | 54.4 |
| Employees | -- | -- | 254 |
| Market Cap ($ mil.) | 1,665.5 | 99.5 | -- |
Competitive Landscape





